Focal therapy IDEAL Prostate cancer

Arteries *Embolization Therapeutic Humans *Lower Urinary Tract Symptoms/etiology Male *Prostatic Hyperplasia/complications/therapy *Radiation Exposure Treatment Outcome *Benign prostatic hyperplasia *Lower urinary tract symptoms *Minimally invasive treatment *Prostatic artery embolisation

Benign prostatic enlargement Benign prostatic hyperplasia Lower urinary tract symptoms Minimally invasive surgical therapies Prostatic urethral lift Rezum Temporary implantable nitinol device UroLift Water vapor thermal therapy iTind

Humans Lower Urinary Tract Symptoms Male Network Meta-Analysis Phytotherapy Plant Extracts Prostate/*drug effects Prostatic Hyperplasia/*drug therapy Randomized Controlled Trials as Topic *Serenoa Treatment Outcome *Benign prostatic hyperplasia *Lower urinary tract symptoms *Medical therapy *Phytotherapy *Prostate *Saw palmetto

*Erectile Dysfunction/etiology Humans *Lower Urinary Tract Symptoms/diagnosis/etiology/surgery Male Network Meta-Analysis *Prostatic Hyperplasia/complications/surgery *Transurethral Resection of Prostate *Benign prostatic hyperplasia *Benign prostatic obstruction *Ejaculation *Ejaculatory dysfunction *Erectile dysfunction *Erectile function *International Index of Erectile Function-5 *Network meta-analysis *Prostatic urethral lift *Sexual function

Benign prostatic hyperplasia Meta-analysis Prostatic urethral lift Sexual function Systematic review

Consensus Molecular Taxonomy Muscle-invasive Bladder Cancer Transcriptomic Classifier.

Adult Embolization Therapeutic/*adverse effects/methods Humans Lower Urinary Tract Symptoms/*etiology Male Middle Aged Patient Reported Outcome Measures Penile Erection/physiology Prostate/blood supply Prostatic Hyperplasia/*therapy Randomized Controlled Trials as Topic Safety Treatment Outcome Benign prostatic hyperplasia Lower urinary tract symptoms Prostatic artery embolization Systematic review

Biomarkers/analysis Humans Male MicroRNAs/*analysis Prostatic Hyperplasia/*diagnosis/metabolism Benign prostatic hyperplasia Diagnosis Prostate cancer Therapy miRNA

Humans Length of Stay Male Perioperative Period Prostate/pathology Prostatic Hyperplasia/epidemiology/pathology Randomized Controlled Trials as Topic Saline Solution Transurethral Resection of Prostate/*adverse effects/*economics/standards Treatment Outcome United Kingdom/epidemiology Urethral Stricture/complications Urologic Surgical Procedures *Bph *Benign prostate enlargement *Benign prostate hyperplasia *Cost minimisation analysis *Meta-analysis *TUR syndrome *Turp *TURis *Transurethral resection in saline *Transurethral resection of the prostate

5α-Reductase inhibitors Benign prostatic hyperplasia Erectile dysfunction Finasteride Lower urinary tract symptoms Meta-analysis Permixon Phytotherapy Randomized controlled trial Serenoa repens Systematic review Tamsulosin α-Blockers

Humans Cystectomy/adverse effects/methods *Urinary Bladder Neoplasms/surgery/etiology Urinary Bladder *Urinary Diversion/adverse effects/methods *Acidosis/epidemiology/etiology/therapy Acidosis metabólica Bicarbonate Bicarbonato Bladder tumor Cistectomía radical Derivación urinaria Metabolic acidosis Radical cystectomy Tratamiento Treatment Tumor vesical Urinary diversion

膀胱镜 膀胱肿瘤 成像 三维

Humans Mitomycin Gemcitabine Hematuria *Non-Muscle Invasive Bladder Neoplasms Deoxycytidine/therapeutic use Administration Intravesical *Urinary Bladder Neoplasms/drug therapy *Cystitis Chemical cystitis Cistitis química Cáncer de vejiga sin invasión muscular Gemcitabina intravesical Intravesical gemcitabine Intravesical mitomycin Mitomicina intravesical Non-muscle invasive bladder cancer Recurrence rates Tasas de recurrencia

Bladder cancer Hpv Human papillomavirus Meta-analysis

Cohort Studies *Dietary Fats/adverse effects Female Humans Male Prospective Studies Risk Factors Sugars *Urinary Bladder Neoplasms/epidemiology/etiology bladder cancer diet epidemiology fat oil risk factor

Biomarkers/urine Carcinogenesis Carcinogens/toxicity Female Humans Male *Tobacco Products/adverse effects *Urinary Bladder Neoplasms/etiology Biomarkers of exposure Bladder cancer Carcinogens Heated tobacco product Urine disclosures.

Data Systems Humans Magnetic Resonance Imaging/methods *Multiparametric Magnetic Resonance Imaging Reproducibility of Results Urinary Bladder/diagnostic imaging/pathology *Urinary Bladder Neoplasms/diagnostic imaging/surgery Bladder cancer Bladder cancer staging Multiparametric magnetic resonance imaging Muscle-invasive bladder cancer conflict of interest to disclose.

膀胱癌 整块切除 二次电切 肿瘤残留 分期升高

*Carcinoma Transitional Cell/drug therapy Female Humans Immune Checkpoint Inhibitors/therapeutic use Immunotherapy *Lung Neoplasms/pathology Male Platinum/therapeutic use Programmed Cell Death 1 Receptor *Urinary Bladder Neoplasms/drug therapy